Novel method for reducing plasma cholesterol: a ligand replacement therapy.
Novel method for reducing plasma cholesterol: a ligand replacement therapy.
复制标题
DOI：
10.2217/clp.14.63
复制
发表时间：
2015-01-01
影响因子：
--
通讯作者：
Goldberg D
中科院分区：
文献类型：
--
作者：
Anantharamaiah GM;Goldberg D
Despite wide use of statins, significant cardiovascular disease risk persists. High-density lipoprotein based therapy has not yielded any positive results in combating this disease. Newer methods to rapidly decrease plasma cholesterol are much needed. While apolipoprotein B is a ligand for low-density lipoprotein receptor, which clears low-density lipoprotein cholesterol in a highly regulated pathway, apolipoprotein E (apoE) is a ligand for clearing other apolipoprotein B containing atherogenic lipoproteins via an alternate receptor pathway, especially the heparin sulfate proteoglycans on the liver cell surface. We describe here a novel method that replaces apoE as a ligand to clear all of the atherogenic lipoproteins via the heparin sulfate proteoglycans pathway. This ligand replacement apoE mimetic peptide therapy, having been designated as an orphan drug by the US FDA, is in clinical trials.
登录
查看更多内容
影响因子：
37.8
作者：
Gupta, H;White, CR;Anantharamaiah, GM
通讯作者：
Anantharamaiah, GM
影响因子：
6.9
作者：
Christianson, Helena C.;Belting, Mattias
通讯作者：
Belting, Mattias
影响因子：
56.9
作者：
BROWN, MS;GOLDSTEIN, JL
通讯作者：
GOLDSTEIN, JL
影响因子：
64.5
作者：
BROWN, MS;GOLDSTEIN, JL
通讯作者：
GOLDSTEIN, JL
影响因子：
6.5
作者：
Ason, Brandon;van der Hoorn, Jose W. A.;Jackson, Simon
通讯作者：
Jackson, Simon